Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.

BGLC

BioNexus Gene Lab (PK) (BGLC)

BioNexus Gene Lab Corporation (PK)
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:USOTC:BGLC
FechaHoraFuenteTítuloSímboloCompañía
15/05/202412:20Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:BGLCBioNexus Gene Lab Corporation (PK)
18/04/202412:44Edgar (US Regulatory)Form 8-K - Current reportUSOTC:BGLCBioNexus Gene Lab Corporation (PK)
16/04/202412:00Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]USOTC:BGLCBioNexus Gene Lab Corporation (PK)
28/03/202414:59Edgar (US Regulatory)Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405USOTC:BGLCBioNexus Gene Lab Corporation (PK)
26/03/202414:59Edgar (US Regulatory)Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]USOTC:BGLCBioNexus Gene Lab Corporation (PK)
29/02/202416:16Edgar (US Regulatory)Form DEF 14C - Other definitive information statementsUSOTC:BGLCBioNexus Gene Lab Corporation (PK)
14/11/202310:54Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:BGLCBioNexus Gene Lab Corporation (PK)
30/10/202311:14Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]USOTC:BGLCBioNexus Gene Lab Corporation (PK)
17/10/202310:46Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsUSOTC:BGLCBioNexus Gene Lab Corporation (PK)
04/10/202314:57Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesUSOTC:BGLCBioNexus Gene Lab Corporation (PK)
21/07/202314:37Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]USOTC:BGLCBioNexus Gene Lab Corporation (PK)
20/07/202311:28Edgar (US Regulatory)Form CERT - Certification by an exchange approving securities for listingUSOTC:BGLCBioNexus Gene Lab Corporation (PK)
19/07/202323:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessUSOTC:BGLCBioNexus Gene Lab Corporation (PK)
19/07/202313:35Edgar (US Regulatory)Form 8-A12B - Registration of securities [Section 12(b)]USOTC:BGLCBioNexus Gene Lab Corporation (PK)
17/05/202308:07Edgar (US Regulatory)Information Statement - All Other (definitive) (def 14c)USOTC:BGLCBioNexus Gene Lab Corporation (PK)
09/05/202310:40Edgar (US Regulatory)Quarterly Report (10-q)USOTC:BGLCBioNexus Gene Lab Corporation (PK)
31/03/202308:58Edgar (US Regulatory)Annual Report (10-k)USOTC:BGLCBioNexus Gene Lab Corporation (PK)
10/03/202309:35Edgar (US Regulatory)Information Statement (definitive, Revised) (defr14c)USOTC:BGLCBioNexus Gene Lab Corporation (PK)
14/02/202313:38Edgar (US Regulatory)Securities Registration Statement (s-1)USOTC:BGLCBioNexus Gene Lab Corporation (PK)
15/08/202214:36Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BGLCBioNexus Gene Lab Corporation (PK)
01/04/202216:19Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:BGLCBioNexus Gene Lab Corporation (PK)
09/11/202008:13Edgar (US Regulatory)Amended Quarterly Report (10-q/a)USOTC:BGLCBioNexus Gene Lab Corporation (PK)
 Showing the most relevant articles for your search:USOTC:BGLC

Su Consulta Reciente

Delayed Upgrade Clock